Translational research is a melding of basic science principles and clinical practice, forming a bridge between the laboratory and the patient. This type of research is essential to advancing medical discoveries and improving patient health. Translational research typically begins with basic research involving scientists like biologists and chemists creating new tools and discoveries in the lab. For example, they might develop a new drug or surgical procedure. This foundational work is used to create therapeutic applications or treatments for illnesses and diseases in the clinical setting. For instance, a drug that was identified initially in a laboratory might be studied further to determine what molecules it could target, its possible side effects, and dosage regimens. After going through multiple phases of clinical trials to monitor safety and efficacy, the drug would then be able to be prescribed to actual patients. Notably, translational research often involves multi-disciplinary collaborations to prompt better communication across various specialties and achieve faster results. Translational research is often aimed toward specific populations, like elderly people or children, or a particular focused area such as cancer. Through this research, advances in medical knowledge can be achieved, and new drugs and treatments can be delivered to people in need. In conclusion, translational research is a vital part of the medical process. It bridges clinical practice and basic science discoveries, providing insights into new treatments that can save lives. It also serves to give scientists a clearer view of the medical field, as well as what new tools could be developed to improve health overall.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States